Nepafenac Patent Expiration
Nepafenac is Used for treating ocular inflammation. It was first introduced by Harrow Eye Llc
Nepafenac Patents
Given below is the list of patents protecting Nepafenac, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ilevro | US5475034 | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
Jun 06, 2014
(Expired) | Harrow Eye |
| Ilevro | US6403609 | Ophthalmic compositions containing galactomannan polymers and borate |
Jul 17, 2018
(Expired) | Harrow Eye |
| Ilevro | US7947295 | Ophthalmic compositions containing a synergistic combination of two polymers |
Jun 08, 2024
(Expired) | Harrow Eye |
| Ilevro | US8921337 | Carboxyvinyl polymer-containing nanoparticle suspensions | Mar 31, 2032 | Harrow Eye |
| Ilevro | US9662398 | Carboxylvinyl polymer-containing nanoparticle suspensions | Dec 01, 2030 | Harrow Eye |
| Nevanac | US5475034 | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
Jun 06, 2014
(Expired) | Harrow Eye |
| Nevanac | US7834059 | Topical nepafenac formulations | Jan 31, 2027 | Harrow Eye |
| Nevanac | US8071648 | Topical nepafenac formulations | Dec 02, 2025 | Harrow Eye |
| Nevanac | US8324281 | Topical nepafenac formulations | Dec 02, 2025 | Harrow Eye |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳